MedTrace Logo

Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System

NCT01491945 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2021-10-15

Study results available
· View outcomes & findings →

Summary

The purpose of this trial is to determine if the Ventana Fenestrated Stent Graft System is safe and effective for the endovascular repair of juxtarenal or pararenal aortic aneurysms.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

Ventana Fenestrated Stent Graft System

The Ventana Fenestrated Stent Graft System consists of the following: bifurcated stent graft, Ventana fenestrated proximal extension stent graft, and Xpand renal stent grafts

Sponsors & Collaborators

  • Endologix

    lead INDUSTRY

Principal Investigators

  • Daniel G Clair, MD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-03
Primary Completion
2017-04-30
Completion
2018-08-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01491945 on ClinicalTrials.gov